How to Report a Stem Cell Clinic for Harm or Deceptive Claims

Knowing how to report a stem cell clinic comes down to three separate agencies: file with the Food and Drug Administration (FDA) for physical harm or adverse events, the Federal Trade Commission (FTC) for deceptive marketing, and your state medical board for physician misconduct. At Medical Frontier, we guide patients and families through the regulatory realities of regenerative medicine treatments that clinics sell without federal approval.

This guide details the specific forms, phone numbers, and agency databases used to record complaints against clinics selling unapproved regenerative therapies.

How to Report a Stem Cell Clinic Across the Three Main Channels

Three agencies handle stem cell clinic reports, and each one covers a different kind of problem. The proper reporting destination depends directly on what went wrong during your clinic encounter:

1. For bodily harm, infections, or unexpected medical complications: Report directly to the Food and Drug Administration (FDA) through the MedWatch program. The FDA tracks biological product safety issues and unapproved drug distribution.
2. For false advertising, fake cure promises, or financial deception: Report directly to the Federal Trade Commission (FTC). The FTC investigates deceptive commercial practices and false health marketing claims.
3. For physician malpractice, unlicensed practitioners, or missing informed consent: Report directly to your state medical board via the Federation of State Medical Boards (FSMB). Only state licensing boards hold the authority to restrict or revoke a doctor’s license to practice medicine.

If you experienced both physical harm and fraudulent financial promises, you can file separate complaints with all three bodies. Each agency handles a distinct legal jurisdiction. None of these agencies share complaint queues automatically, so a filing with one will not transfer to the others.

Harm Reporting to the FDA Through MedWatch

The Food and Drug Administration (FDA) encourages any patient who experienced an adverse event or physical harm from a regenerative procedure to file an official report through its MedWatch program. This applies to products marketed as stem cells, exosomes, cord blood, amniotic fluid, or Platelet-Rich Plasma (PRP).

You can submit an FDA MedWatch report through three administrative routes:

• Online submission: Use the MedWatch Online Voluntary Reporting Form accessible through the official FDA adverse event reporting portal. This is the fastest method to enter an injury into the federal tracking database.
• Fax submission: Download and complete the MedWatch voluntary reporting form, then fax it directly to 1-800-FDA-0178.
• Mail submission by phone request: Call 1-800-332-1088 to request a paper copy of the reporting form by mail. Once completed, you can mail it back using the prepaid postage envelope or fax it to 1-800-FDA-0178.

Either the patient, a family member, or a licensed healthcare professional can submit the report. The form asks for the name and contact information of the person submitting the complaint in case agency reviewers need additional medical records.

The FDA aggregates these individual submissions into an active database. Reviewers use this data to identify unsafe biological products, contaminated preparation lots, and dangerous medical procedures across the country. Filing a report does not establish a personal lawsuit, but it alerts federal regulators to harmful biological products distributed without premarket approval. For documented clinical risks associated with these injections, review our guide to stem cell safety and side effects.

Deceptive Marketing Complaints to the FTC

The Federal Trade Commission (FTC) investigates and prosecutes commercial businesses that use misleading health claims to extract cash from consumers. If a regenerative medicine business promised a guaranteed joint repair, reversal of neurological degeneration, or relief from systemic diseases without clinical proof, that clinic falls under FTC enforcement jurisdiction.

To file a formal consumer complaint, visit reportfraud.ftc.gov. The FTC collects complaint submissions to build investigative records against fraudulent medical marketers. This information feeds a secure database shared among civil and criminal law enforcement agencies at federal, state, and local levels.

Submitting reports to the FTC produces real enforcement results. The agency has repeatedly taken legal action against unproven stem cell operations:

• In January 2025, the FTC announced that the co-founders and affiliated corporate entities behind the Stem Cell Institute of America were banned from marketing stem cell treatments and ordered to pay more than $5.1 million in customer refunds and civil penalties.
• That permanent ban resulted from a joint lawsuit filed in August 2021 by the FTC and the Georgia Attorney General. The regulators proved the enterprise targeted elderly patients with deceptive claims that unapproved injections could rehabilitate damaged joints, treat osteoarthritis, and eliminate chronic pain.
• In October 2018, the FTC settled formal deceptive advertising charges against a California physician and two operating companies he managed. The settlement penalized false marketing that claimed amniotic stem cell injections could effectively treat autism, Parkinson’s disease, macular degeneration, cerebral palsy, multiple sclerosis, and heart attacks.

These enforcement outcomes demonstrate that consumer filings generate actionable federal lawsuits. When filing, document the specific marketing promises made during seminar presentations, clinic consultations, or promotional emails.

Physician Misconduct Reports to State Medical Boards

State medical boards regulate individual medical licenses rather than biological manufacturing standards or corporate advertising practices. If the individual recommending or performing the injection acted recklessly, misrepresented their professional credentials, or failed to secure proper consent, your state medical board is the governing body that investigates.

Every state maintains its own independent medical board with statutory authority to issue formal reprimands, order mandatory retraining, impose administrative fines, or suspend and revoke a physician’s license to practice medicine. Neither the FDA nor the FTC can revoke a physician’s medical license. That authority belongs exclusively to state boards.

To file a state medical board complaint, follow these steps:

1. Locate your state’s regulatory body using the official FSMB consumer directory.
2. Review the specific filing guidelines posted on your state board’s portal. Most state boards require complaints in writing, either through an online portal, an uploaded affidavit, or a paper form delivered by mail or fax.
3. Detail the treating clinician’s exact actions, including whether they personally examined you, what risks they disclosed, and who actually administered the biological injection.

Failure to obtain informed consent represents a primary basis for state board disciplinary action. On August 12, 2019, the International Society for Stem Cell Research (ISSCR) released a professional informed consent standard specifically for clinicians offering stem cell interventions outside recognized clinical trials.

The ISSCR standard obligates clinicians to disclose the biological rationale behind the treatment, provide a transparent assessment of potential risks and benefits, and explicitly inform the patient that the intervention remains experimental. If a practitioner failed to provide these disclosures before accepting your payment, state that omission clearly in your written board complaint.

Comparison of the Three Regulatory Pathways

Selecting the right reporting route ensures your complaint reaches the correct regulatory personnel without administrative delays.

Evidence Needed for How to Report a Stem Cell Clinic

Gathering specific records before opening an online reporting form improves the utility of your submission for regulatory investigators. Federal and state staff evaluate patterns of conduct across multiple complaints, so precise documentation strengthens their case files.

Collect the following materials if you have access to them:

• Product details: Note the exact product name, manufacturer, and lot number if listed on your medical summary. State whether the clinic marketed the product as umbilical cord stem cells, amniotic fluid, exosomes, or autologous bone marrow aspirate concentrate.
• Financial records: Retain bank statements, credit card receipts, and clinic invoices detailing the out-of-pocket fees charged. Cash clinics typically bill thousands of dollars outside insurance coverage.
• Promotional collateral: Save clinic brochures, presentation slides from hotel seminars, printed intake questionnaires, and printouts of website pages promising permanent tissue regeneration.
• Medical documentation: Gather records showing your pre-treatment baseline health, post-injection emergency room admissions, infectious disease lab cultures, or corrective surgeries required to treat complications.
• Consent documents: Locate copies of all paperwork signed prior to the injection, particularly forms that omitted the experimental status of the procedure or attempted to waive your legal rights.

If you lack some of these records, file your complaint anyway. You do not need a complete legal brief to alert regulators to dangerous or fraudulent practices.

Filing Steps for How to Report a Stem Cell Clinic With Fake Trials

Many unapproved clinics attempt to legitimize high-cost procedures by telling prospective patients that their cash payment enrolls them in an official research study. Real interventional clinical trials do not charge patients thousands of dollars for experimental biological therapies.

Legitimate clinical trials receive review from an Institutional Review Board (IRB) and register publicly on ClinicalTrials.gov with a dedicated National Clinical Trial (NCT) identification number. If a clinic claimed you were entering a formal study but cannot provide an active NCT number matching your exact condition and treatment protocol, that deceptive claim should be included directly in your FTC and state medical board reports.

To learn how to verify legitimate trial numbers and separate real research from consumer fee schemes, read our detailed guide on clinical trials versus cash clinics. You can also review key regulatory terms in our regenerative medicine glossary to describe trial misrepresentations accurately in your report.

Who This Guidance Does Not Serve

This reporting guide is designed for individuals who have already encountered physical harm, financial misrepresentation, or ethical breaches from a regenerative medicine provider.

This guidance does not serve patients who are still in the preliminary research phase and trying to decide whether to book an initial consultation. If you have not yet scheduled an appointment or transferred funds to a provider, filing an agency complaint is premature. Instead, follow our step-by-step framework on how to vet a stem cell clinic to audit provider credentials, cross-reference biologics registrations, and identify marketing red flags before any money changes hands.

Triggers That Would Change This Reporting Pathway

The three-channel pathway outlined above applies specifically to outpatient clinics selling unapproved regenerative biological products such as stem cells, exosomes, and birth tissue derivatives.

Specific circumstances would redirect your reporting steps:

• Controlled substance violations: If a clinic administered unprescribed narcotics, unapproved sedatives, or illicit pharmaceuticals alongside biological injections, report those actions to local law enforcement rather than relying solely on the FTC.
• Surgical hospital negligence: If malpractice occurred inside an accredited hospital during an FDA-approved, insurance-billed procedure rather than a cash-pay clinic injection, that is a hospital-accreditation and medical-malpractice matter, not a MedWatch case. Your state medical board complaint above still applies to the individual physician.
• International clinic operations: If you received stem cell injections at a clinic outside the US, US federal agencies hold limited enforcement authority over that facility. Reports regarding overseas injuries generally need to go to that country’s own health regulator, such as COFEPRIS in Mexico, alongside a dispute filed with your payment card issuer.

Next Steps for Affected Patients

If you suffered an infection, physical injury, or deceptive financial loss from an unapproved regenerative procedure, start your complaint process immediately by completing an online MedWatch filing for bodily harm or an FTC fraud report for misleading commercial claims. Submitting your formal account ensures regulatory agencies possess the necessary evidence to restrict predatory practices, revoke medical licenses, and halt deceptive biological claims across the medical marketplace. To protect yourself or family members from future unverified treatments, learn how to report a stem cell clinic to federal authorities while referencing the legal boundaries established in our FDA approval guide.

Frequently asked questions

How do I report a stem cell clinic to the FDA?

Submit a report through the MedWatch voluntary reporting program using the online reporting form on the Food and Drug Administration (FDA) adverse event reporting page. You can also submit the same form by faxing it to 1-800-FDA-0178. If you prefer a paper copy, call 1-800-332-1088 to request one by mail, then complete and return it.

Where do I report false stem cell marketing claims?

Report deceptive marketing or unproven medical claims directly to the Federal Trade Commission (FTC) at reportfraud.ftc.gov. The FTC collects reports about misleading cure claims, arthritis treatments, and unproven health advertising to support civil enforcement actions. The information enters a shared database used by the FTC and civil law enforcement partners.

Can the FTC get my money back from a stem cell clinic?

The FTC sometimes secures consumer refunds through major court settlements, but filing an individual complaint does not guarantee money back. In January 2025, an FTC case resulted in more than $5.1 million in refunds and civil penalties against clinic promoters. However, the agency acts on behalf of the public rather than serving as an individual collections service.

How do I file a complaint against a doctor for an unproven stem cell treatment?

Locate your state's licensing authority through the Federation of State Medical Boards (FSMB) directory. Contact the board directly to obtain its specific written complaint form, which you can submit online, by mail, or by fax depending on the state. State medical boards investigate physician conduct and hold the sole legal power to suspend or revoke medical licenses.

What is MedWatch?

MedWatch is the FDA safety information and adverse event reporting program used by patients and medical professionals. It allows consumers and clinicians to voluntarily report side effects, infections, or injuries caused by medical products, including unapproved stem cell or exosome injections. The FDA uses MedWatch submissions to detect safety signals across facilities.

Has the FTC ever actually taken action against a stem cell clinic?

Yes. In January 2025, the FTC announced that the co-founders and companies behind the Stem Cell Institute of America were banned from marketing stem cell treatments and ordered to pay more than $5.1 million in refunds and penalties. The FTC also settled deceptive advertising charges against a California physician in 2018 for marketing unproven amniotic stem cell treatments for neurological and cardiac conditions.

Do I need proof to report a stem cell clinic?

You do not need legal proof to submit a report to the FDA, FTC, or a state medical board. You only need to describe what occurred, what products were administered, what you paid, and any physical harm you experienced. Providing treatment receipts, consent forms, promotional brochures, or clinician names helps investigators substantiate the pattern of conduct.

What is the difference between reporting a clinic and vetting one before I pay?

Reporting happens after an injury, severe side effect, or deceptive transaction has already occurred, alerting regulatory agencies to dangerous conduct. Vetting happens beforehand to verify regulatory registrations, physician credentials, and trial listings so you avoid paying for unproven procedures. If you have not received treatment yet, consult our guide on vetting a clinic before scheduling an appointment.